Engineered trivalent immunogen adjuvanted with a STING agonist confers protection against Trypanosoma cruzi infection
Chagas disease: protecting from chronic parasitic disease An amalgamation of parasitic proteins may be the first effective vaccine against the as yet untreatable chronic phase of Chagas disease. The infliction, caused by the parasite Trypanosoma cruzi (T. cruzi), is the world’s leading cause of infe...
Guardado en:
Autores principales: | Andrés Sanchez Alberti, Augusto E. Bivona, Natacha Cerny, Kai Schulze, Sebastian Weißmann, Thomas Ebensen, Celina Morales, Angel M. Padilla, Silvia I. Cazorla, Rick L. Tarleton, Carlos A. Guzmán, Emilio L. Malchiodi |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/ae1f0273188b48babe69f8e20ee1e766 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Protein Profiles of Trypanosoma cruzi and Trypanosoma rangeli
por: MEJÍA,ASTRID J, et al.
Publicado: (2004) -
A semantic problem solving environment for integrative parasite research: identification of intervention targets for Trypanosoma cruzi.
por: Priti P Parikh, et al.
Publicado: (2012) -
ExoSTING, an extracellular vesicle loaded with STING agonists, promotes tumor immune surveillance
por: Su Chul Jang, et al.
Publicado: (2021) -
Natural reservoirs of Trypanosoma cruzi
Publicado: (2000) -
CRISPR-Cas9-Mediated Single-Gene and Gene Family Disruption in <named-content content-type="genus-species">Trypanosoma cruzi</named-content>
por: Duo Peng, et al.
Publicado: (2015)